
Job Title: Director to Senior Director, Structural Biology
Reports To: VP, Head of Discovery Unit 3
Location: Shanghai, China
About Us:
Structure Therapeutics develops life‐changing medicines for patients using advanced structure‐based and computational drug discovery technology. The company’s platform combines the latest advancements in visualization of molecular interactions, computational chemistry, and data integration to design orally available, superior small molecule medicines that overcome current limitations of biologic and peptide drugs. We are advancing a clinical‐stage pipeline of differentiated treatments focused on chronic diseases with high unmet need, including cardiovascular, metabolic, and pulmonary conditions.
Structure Therapeutics is led by an experienced group of international drug innovators and financed by top-tier global life sciences investors. The company completed an initial public offering (IPO) in February 2023. With offices in California and Shanghai, Structure Therapeutics has the benefit of being at the center of life science innovation in both the US and China and capitalizing on the strengths of each geographic location.
In this role, you will join a motivated team of scientists contributing to pipeline projects with a focus on determining structures of drug targets in complex with molecules, to influence all stages of our drug discovery efforts. In addition, you will be involved in making innovative contributions to understand the fundamental regulatory mechanisms of drug targets by structural biology. You will work closely with teams in other functional areas and with CROs.
Structure Therapeutics is seeking a Scientist to join our drug discovery team as a key member. The ideal candidate will hold a Doctorate degree in structural biology and will be an enthusiastic contributor to our fast-paced interdisciplinary team. This team is dedicated to advancing our groundbreaking technology platform, with a focus on discovering novel lead candidates for clinical development.
The successful candidate will possess excellent communication skills, strategic thinking abilities, and scientific knowledge, with specific expertise in protein chemistry, membrane protein cryo-electron microscopy.
Responsibilities for this position include maintaining and accelerating our structure-based drug discovery through hands-on engagement in projects to ensure efficient generation of crucial structural information.
As a crucial part of our integrative platform, the successful candidate will also be responsible for analyzing, organizing, and curating primary data generated from structural biology and protein assay activities, and s(he) will be required to integrate this information with medicinal chemists, computational chemists, and biologists.
Working closely as a team member with experienced drug hunters, the Scientist will gain significant experience in the Structure Therapeutics drug discovery system. This position presents a unique opportunity for the individual to make a major contribution to the success of a well-positioned growth stage US-China biopharmaceutical company.
Job Responsibilities:
Qualifications:
Core Competencies, Knowledge and Skill Requirements
Communication & Interpersonal Skills
Experience
Structure Therapeutics Inc. is an Equal-Opportunity Employer.
Structure Therapeutics is committed to fair and equitable compensation practices, and we strive to provide employees with total compensation packages that are market competitive. The exact base pay offered for this role will depend on various factors, including but not limited to the candidate’s geography, qualifications, skills, and experience.
At Structure, base pay is only one part of your total compensation package. The successful candidate will be eligible for an annual performance incentive bonus, new hire equity, ongoing performance-based equity and various benefits offerings.

Structure Therapeutics is a science-driven clinical-stage biopharmaceutical company focused on discovering and developing innovative oral small molecule treatments for chronic metabolic and cardiopulmonary conditions with significant unmet medical needs. Utilizing its next generation structure-based drug discovery platform, Structure Therapeutics has established a robust GPCR-targeted pipeline, featuring multiple wholly-owned proprietary clinical-stage small molecule compounds designed to surpass the scalability limitations of traditional biologic and peptide therapies and be accessible to more patients around the world.